Company Overview - Sernova Corp. is a clinical-stage company focused on developing regenerative medicine therapeutics, specifically its Cell Pouch bio-hybrid organ aimed at treating type 1 diabetes and thyroid disorders [2]. Meeting Announcement - Sernova Corp. will hold its annual general and special meeting of shareholders on January 10, 2025, at 1:00 PM ET, postponed from January 7, 2025, due to a postal strike in Canada [1]. - The record date for the meeting remains November 12, 2024, and proxies must be submitted by January 8, 2025, at 1:00 PM ET [6]. Technology and Innovation - The Cell Pouch is designed to integrate with living tissue, replicating or enhancing the function of natural organs, which could provide revolutionary treatment options for chronic diseases [2].
Sernova Reschedules its Annual General and Special Meeting of Shareholders to January 10, 2025